Nutrition and hypertension: More than table salt;Alimentation et hypertension artérielle: Au-delà du sel de table

Revue Medicale Suisse

Volumn 6, Issue 262, 2010, Pages 1715-1720

  Pruijm, Menno ^a   Wuerzer, Grégoire ^a   Forni, Valentina ^a   Bochud, Murielle ^b   Pechère Bertschi, Antoinette ^c   Burnier, Michel ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c Services d'Endocrinologie   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CALCIUM; FOLIC ACID; FRUCTOSE; POTASSIUM; SODIUM CHLORIDE; VITAMIN D;

BLOOD PRESSURE; DIETARY FIBER; DIETARY INTAKE; GARLIC; HUMAN; HYPERTENSION; NUTRITION; REVIEW; SODIUM INTAKE;

BEVERAGES; CACAO; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; DIETARY FIBER; GARLIC; HUMANS; HYPERTENSION; MILK PROTEINS; PEPTIDES; POTASSIUM, DIETARY; SODIUM, DIETARY;

EID: 77957330486     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206.
2. Firmann M, Mayor V, Vidal PM, et al. The CoLaus study: A population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 2008;8:6. (Pubitemid 351566647)
3. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-52.
4. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362:590-9.
5. Nguyen S, Choi HK, Lustig RH, Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009;154:807-13.
6. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13.
7. Johnson RJ, Segal MS, Sautin Y, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007;86:899-906. (Pubitemid 47538288)
8. Malik VS, Schulze MB, Hu FB. Intake of sugar-sweetened beverages and weight gain: A systematic review. Am J Clin Nutr 2006;84:274-88.
9. Singh AS, Chin APM, Brug J, van MW. Dutch obesity intervention in teenagers: Effectiveness of a school-based program on body composition and behavior. Arch Pediatr Adolesc Med 2009;163:309-17.
10. Price SR, Hilchey CA, Darredeau C, Fulton HG, Barrett SP. Energy drink co-administration is associated with increased reported alcohol ingestion. Drug Alcohol Rev 2010;29:331-3.
11. Geleijnse JM. Habitual coffee consumption and blood pressure: An epidemiological perspective. Vasc Health Risk Manag 2008;4:963-70.
12. Sharifi AM, Darabi R, Akbarloo N. Investigation of antihypertensive mechanism of garlic in 2K1C hypertensive rat. J Ethnopharmacol 2003;86:219-24.
13. Silagy CA, Neil HA. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994;12:463-8.
14. Ried K, Frank OR, Stocks NP, Fakler P, Sullivan T. Effect of garlic on blood pressure : A systematic review and meta-analysis. BMC Cardiovasc Disord 2008;8:13.
15. Corti R, Perdrix J, Rammer AJ, Noll G. Dark or white chocolate? Cocoa and cardiovascular health. Rev Med Suisse 2010;6:499-4.
16. Flammer AJ, Hermann F, Sudano I, et al. Dark chocolate improves coronary vasomotion and reduces platelet reactivity. Circulation 2007;116:2376-82. (Pubitemid 350145072)
17. Ried K, Sullivan T, Fakler P, Frank OR, Stocks NP. Does chocolate reduce blood pressure? A meta-analysis. BMC Med 2010;8:39.
18. Streppel MT, Arends LR, van t' Veer V, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: A meta-analysis of randomized placebo-controlled trials. Arch Intern Med 2005;165:150-6.
19. Wuerzner G, Peyrard S, Blanchard A, Lalanne F, Azizi M. The lactotripeptides isoleucine-proline-proline and valine-proline-proline do not inhibit the N-terminal or C-terminal angiotensin converting enzyme active sites in humans. J Hypertens 2009;27:1404-9.
20. Geleijnse JM, Engberink MF. Lactopeptides and human blood pressure. Curr Opin Lipidol 2010;21:58-63.
21. Tunstall-Pedoe H. Does dietary potassium lower blood pressure and protect against coronary heart disease and death? Findings from the Scottish heart health study? Semin Nephrol 1999;19:500-1
22. Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA 1997;277:1624-31
23. Geleijnse JM, Kok FJ, Grobbee DE. Blood pressure response to changes in sodium and potassium intake: A metaregression analysis of randomised trials. J Hum Hypertens 2003;17:471-80.
24. Gallen IW, Rosa RM, Esparaz DY, et al. On the mechanism of the effects of potassium restriction on blood pressure and renal sodium retention. Am J Kidney Dis 1998;31:19-27.
25. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative research group. N Engl J Med 1997;336:1117-24.